-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
-
(2010)
Int J Cancer
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
3
-
-
53149152246
-
Prognostic value of extracapsular invasion and fibrotic focus in single lymph node metastasis of gastric cancer
-
Okamoto T, Tsuburaya A, Kameda Y, et al: Prognostic value of extracapsular invasion and fibrotic focus in single lymph node metastasis of gastric cancer. Gastric Cancer 11: 160-167, 2008.
-
(2008)
Gastric Cancer
, vol.11
, pp. 160-167
-
-
Okamoto, T.1
Tsuburaya, A.2
Kameda, Y.3
-
4
-
-
80054071524
-
Molecularly targeted therapies in unresectable-metastatic gastric cancer: A systematic review
-
Zagouri F, Papadimitriou CA, Dimopoulos MA and Pectasides D: Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review. Cancer Treat Rev 37: 599-610, 2011.
-
(2011)
Cancer Treat Rev
, vol.37
, pp. 599-610
-
-
Zagouri, F.1
Papadimitriou, C.A.2
Dimopoulos, M.A.3
Pectasides, D.4
-
5
-
-
82055185791
-
Molecular pathology of gastric carcinoma
-
Jang BG and Kim WH: Molecular pathology of gastric carcinoma. Pathobiology 78: 302-310, 2011.
-
(2011)
Pathobiology
, vol.78
, pp. 302-310
-
-
Jang, B.G.1
Kim, W.H.2
-
6
-
-
38149011286
-
Functional diversity of mammalian type 2C protein phosphatase isoforms: New tales from an old family
-
Lu G and Wang Y: Functional diversity of mammalian type 2C protein phosphatase isoforms: new tales from an old family. Clin Exp Pharmacol Physiol 35: 107-112, 2008.
-
(2008)
Clin Exp Pharmacol Physiol
, vol.35
, pp. 107-112
-
-
Lu, G.1
Wang, Y.2
-
7
-
-
1842483852
-
Arf pathway
-
DOI 10.1038/ng1317
-
Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E and Fornace AJ Jr: Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36: 343-350, 2004. (Pubitemid 38437256)
-
(2004)
Nature Genetics
, vol.36
, Issue.4
, pp. 343-350
-
-
Bulavin, D.V.1
Phillips, C.2
Nannenga, B.3
Timofeev, O.4
Donehower, L.A.5
Anderson, C.W.6
Appella, E.7
Fornace Jr., A.J.8
-
8
-
-
18544385947
-
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
-
Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey T, Lowe SW and Powers S: Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet 31: 133-134, 2002.
-
(2002)
Nat Genet
, vol.31
, pp. 133-134
-
-
Li, J.1
Yang, Y.2
Peng, Y.3
Austin, R.J.4
Van Eyndhoven, W.G.5
Nguyen, K.C.6
Gabriele, T.7
McCurrach, M.E.8
Marks, J.R.9
Hoey, T.10
Lowe, S.W.11
Powers, S.12
-
9
-
-
0037838822
-
Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets
-
Hirasawa A, Saito-Ohara F, Inoue J, Aoki D, Susumu N, Yokoyama T, Nozawa S, Inazawa J and Imoto I: Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin Cancer Res 9: 1995-2004, 2003. (Pubitemid 36687618)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.6
, pp. 1995-2004
-
-
Hirasawa, A.1
Saito-Ohara, F.2
Inoue, J.3
Aoki, D.4
Susumu, N.5
Yokoyama, T.6
Nozawa, S.7
Inazawa, J.8
Imoto, I.9
-
10
-
-
0037446975
-
PPM1D is a potential target for 17q gain in neuroblastoma
-
Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T and Inazawa J: PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res 63: 1876-1883, 2003. (Pubitemid 36460852)
-
(2003)
Cancer Research
, vol.63
, Issue.8
, pp. 1876-1883
-
-
Saito-Ohara, F.1
Imoto, I.2
Inoue, J.3
Hosoi, H.4
Nakagawara, A.5
Sugimoto, T.6
Inazawa, J.7
-
11
-
-
34247099845
-
The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
-
DOI 10.1038/sj.onc.1210032, PII 1210032
-
Demidov ON, Kek C, Shreeram S, Timofeev O, Fornace AJ, Appella E and Bulavin DV: The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. Oncogene 26: 2502-2506, 2007. (Pubitemid 46597262)
-
(2007)
Oncogene
, vol.26
, Issue.17
, pp. 2502-2506
-
-
Demidov, O.N.1
Kek, C.2
Shreeram, S.3
Timofeev, O.4
Fornace, A.J.5
Appella, E.6
Bulavin, D.V.7
-
12
-
-
33846653317
-
Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome
-
DOI 10.1111/j.1349-7006.2007.00395.x
-
Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J and Hirohashi S: Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci 98: 392-400, 2007. (Pubitemid 46195611)
-
(2007)
Cancer Science
, vol.98
, Issue.3
, pp. 392-400
-
-
Loukopoulos, P.1
Shibata, T.2
Katoh, H.3
Kokubu, A.4
Sakamoto, M.5
Yamazaki, K.6
Kosuge, T.7
Kanai, Y.8
Hosoda, F.9
Imoto, I.10
Ohki, M.11
Inazawa, J.12
Hirohashi, S.13
-
13
-
-
80053617156
-
Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas
-
Wang P, Rao J, Yang H, Zhao H and Yang L: Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas. J Surg Oncol 104: 679-684, 2011.
-
(2011)
J Surg Oncol
, vol.104
, pp. 679-684
-
-
Wang, P.1
Rao, J.2
Yang, H.3
Zhao, H.4
Yang, L.5
-
14
-
-
33846520458
-
Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers
-
DOI 10.1007/s10549-006-9304-y
-
Yu E, Ahn YS, Jang SJ, Kim MJ, Yoon HS, Gong G and Choi J: Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers. Breast Cancer Res Treat 101: 269-278, 2007. (Pubitemid 46169880)
-
(2007)
Breast Cancer Research and Treatment
, vol.101
, Issue.3
, pp. 269-278
-
-
Yu, E.1
Ahn, Y.S.2
Jang, S.J.3
Kim, M.-J.4
Yoon, H.S.5
Gong, G.6
Choi, J.7
-
15
-
-
79954664195
-
Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival
-
Satoh N, Maniwa Y, Bermudez VP, Nishimura K, Nishio W, Yoshimura M, Okita Y, Ohbayashi C, Hurwitz J and Hayashi Y: Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival. Cancer Sci 102: 1101-1106, 2011.
-
(2011)
Cancer Sci
, vol.102
, pp. 1101-1106
-
-
Satoh, N.1
Maniwa, Y.2
Bermudez, V.P.3
Nishimura, K.4
Nishio, W.5
Yoshimura, M.6
Okita, Y.7
Ohbayashi, C.8
Hurwitz, J.9
Hayashi, Y.10
-
16
-
-
79952268273
-
Gene amplifications in well-differentiated pancreatic neuroendocrine tumors inactivate the p53 pathway
-
Hu W, Feng Z, Modica I, Klimstra DS, Song L, Allen PJ, Brennan MF, Levine AJ and Tang LH: Gene amplifications in well-differentiated pancreatic neuroendocrine tumors inactivate the p53 pathway. Genes Cancer 1: 360-368, 2010.
-
(2010)
Genes Cancer
, vol.1
, pp. 360-368
-
-
Hu, W.1
Feng, Z.2
Modica, I.3
Klimstra, D.S.4
Song, L.5
Allen, P.J.6
Brennan, M.F.7
Levine, A.J.8
Tang, L.H.9
-
17
-
-
38049074854
-
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
-
Castellino RC, De Bortoli M, Lu X, Moon SH, Nguyen TA, Shepard MA, Rao PH, Donehower LA and Kim JY: Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol 86: 245-256, 2008.
-
(2008)
J Neurooncol
, vol.86
, pp. 245-256
-
-
Castellino, R.C.1
De Bortoli, M.2
Lu, X.3
Moon, S.H.4
Nguyen, T.A.5
Shepard, M.A.6
Rao, P.H.7
Donehower, L.A.8
Kim, J.Y.9
|